Abstract
Eosinophilic meningitis caused by Angiostrongylus cantonensis is an emerging infectious disease. It is the most common form of human angiostrongyliasis. The diagnosis is made by clinical criteria including the presence of cerebrospinal fluid eosinophils and a history of exposure to A. cantonensis larvae, e.g., from raw freshwater snails or contaminated vegetables. Among various treatment options, corticosteroid is the only effective treatment.
Keywords: Angiostrongyliasis, Angiostrongylus cantonensis, cerebrospinal fluid, diagnosis, eosinophilic meningitis, snail, eosinophils, Gnathostoma spinigerum, Taenia solium, Baylisascaris procyonis, gnathostomiasis, baylisascariasis, Angiostrongylus costaricensis, EPIDEMIOLOGY, radiculomyelitis, EoM, EoE, PCR, immunoblotting, Meningoencephalitis, reibergrams, Corticosteroid, Anthelmintics, Prednisolone, mebendazole, albendazole, NSAIDs
Infectious Disorders - Drug Targets
Title: Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis
Volume: 10 Issue: 5
Author(s): Kittisak Sawanyawisuth and Kanlayanee Sawanyawisuth
Affiliation:
Keywords: Angiostrongyliasis, Angiostrongylus cantonensis, cerebrospinal fluid, diagnosis, eosinophilic meningitis, snail, eosinophils, Gnathostoma spinigerum, Taenia solium, Baylisascaris procyonis, gnathostomiasis, baylisascariasis, Angiostrongylus costaricensis, EPIDEMIOLOGY, radiculomyelitis, EoM, EoE, PCR, immunoblotting, Meningoencephalitis, reibergrams, Corticosteroid, Anthelmintics, Prednisolone, mebendazole, albendazole, NSAIDs
Abstract: Eosinophilic meningitis caused by Angiostrongylus cantonensis is an emerging infectious disease. It is the most common form of human angiostrongyliasis. The diagnosis is made by clinical criteria including the presence of cerebrospinal fluid eosinophils and a history of exposure to A. cantonensis larvae, e.g., from raw freshwater snails or contaminated vegetables. Among various treatment options, corticosteroid is the only effective treatment.
Export Options
About this article
Cite this article as:
Sawanyawisuth Kittisak and Sawanyawisuth Kanlayanee, Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, Infectious Disorders - Drug Targets 2010; 10 (5) . https://dx.doi.org/10.2174/187152610793180867
DOI https://dx.doi.org/10.2174/187152610793180867 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets Strategies for Developing Tuberculosis Vaccines: Emerging Approaches
Current Drug Targets Clinical Implications of Recent Insights into the Structural Biology of Beta2 Adrenoceptors
Current Drug Targets Pharmaceutical and Biomedical Applications of Interpenetrating Polymer Network
Current Drug Therapy Moxifloxacin-induced Hypoglycemia in a Non-diabetic Patient
Current Drug Safety COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota
Current Medicinal Chemistry Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update
Current Clinical Pharmacology Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis
Current Pharmaceutical Biotechnology MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of New Hexahydroindazole Derivatives of Curcumin
Letters in Drug Design & Discovery “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
Current Neurovascular Research The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Chemistry and Biological Activities of Buxus Alkaloids
Current Bioactive Compounds Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies The Yin and Yang of Antiviral Innate Immunity in Central Nervous System
Current Pharmaceutical Design Withdrawal Notice: Neuroprotective Effect of Lithospermum officinale callus Extract on Inflamed Primary Microglial Cells
Current Pharmaceutical Biotechnology Murine Skin-resident γδT Cells Impair the Immune Response to HSV in Skin
Infectious Disorders - Drug Targets Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis
Recent Patents on CNS Drug Discovery (Discontinued)